Pansari Developers DuPont analysis

·UnclassifiedChart ›
Per cent unless marked ×
Tap a line for its trendLast 12Mto Jun 2026FY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
5-step DuPont — ROE = tax burden × interest burden × EBIT margin × turnover × leverage
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
0.76×0.76×0.75×0.84×0.74×
2.37×2.10×1.07×1.15×1.01×
12.1%12.9%23.6%9.5%11.6%
0.28×0.28×0.11×0.19×0.08×
1.84×1.84×3.06×2.58×2.35×
11.3%10.7%6.3%4.5%1.6%
13.8%13.8%5.8%4.2%1.7%
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

PANSARI₹265.00

Pansari Developers Limited

· Unclassified
₹ CrorePeersKNAGRIGLOBALNBIFINSHIVAUMFOODSINTARACHANDKOTHARIPETAPOLSINHOTMcap ₹462 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
5-Step DuPont — ROE = Tax Burden × Interest Burden × EBIT Margin × Turnover × Leverage
Tax Burden (Net Income/Pretax) ×0.740.840.750.760.76
Interest Burden (Pretax/EBIT) ×1.011.151.072.102.37
EBIT Margin %11.639.5423.5812.8812.09
Asset Turnover ×0.080.190.110.280.28
Financial Leverage (Assets/Equity) ×2.352.583.061.841.84
ROE (5-step product, year-end total equity) %1.634.526.3110.6611.26
ROE (owners' profit / average owners' equity) %1.684.225.7513.8113.81
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.